CASP3 and non-small cell lung carcinoma: hsa-miR-205-5p may also be involved in the inhibition of TP53, p21 (CDKN1A), and caspase-3 (CASP3) expressions, in NSCLC tumor tissues and MEG3-knockdown NSCLC cell lines [154,157,160].